RRML - Diffuse large B-cell lymphoma – a new look and old prognostic factors
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.493
Five Year Impact Factor 0.531
SNIP 0.373
JCI 0.17


Advanced search


Top 10 downloaded articles
- June 2023 -
 
Screening of a novel BRCA2 mut... 15
The evaluation of a diagnostic... 3
The Role of procollagen type 1... 3
Gene polymorfism of angiotensi... 2
Serum leptin levels in obese c... 2
Versant HCV Genotype 2.0 Assay... 2
Comparison of two analytical m... 2
Cryoglobulins – clinical imp... 2
Renal dysfunction at hospital ... 2
Comparative analysis of GSTM1/... 2

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 20(4)/2012
XML
TXT

Diffuse large B-cell lymphoma – a new look and old prognostic factors

Camelia Dobrea, Hamed Al Salamat, Anca Roxana Lupu


Abstract:

Diffuse large B-cell lymphoma (DLBCL) accounts for about 30% of non-Hodgkin’s lymphoma (NHL) cases. The 2008 WHO Classification of Lymphoid Neoplasms recognizes several clinicopathological variants, subtypes and distinct disease entities of DLBCL. We present a review of clinical, pathological and molecular factors with implication in DLBCL behavior. Even if the golden standard therapy for CD20-positive DLBCL is still represented by R-CHOP, prognostic factor assessment could open new therapeutic perspectives.

Keywords: diffuse large B cell lymphoma,prognostic factors

 
  PDF Download full text PDF
(870 KB)
     
 
How to cite
Dobrea C, Al Salamat H, Lupu AR. Diffuse large B-cell lymphoma – a new look and old prognostic factors. Rev Romana Med Lab. 2012;20(4):307-15